![The metabolite alpha-ketobutyrate extends lifespan by promoting peroxisomal function in C. elegans | Nature Communications The metabolite alpha-ketobutyrate extends lifespan by promoting peroxisomal function in C. elegans | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-023-35899-1/MediaObjects/41467_2023_35899_Fig1_HTML.png)
The metabolite alpha-ketobutyrate extends lifespan by promoting peroxisomal function in C. elegans | Nature Communications
![Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial - The Lancet Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial - The Lancet](https://www.thelancet.com/cms/asset/6d181332-b916-4758-a2fc-707eb4ab0d71/gr1.jpg)
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial - The Lancet
![Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial - The Lancet Healthy Longevity Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial - The Lancet Healthy Longevity](https://www.thelancet.com/cms/asset/e9543d2d-077b-4951-9cb4-c1acc9dd2073/gr1.jpg)
Bimagrumab to improve recovery after hip fracture in older adults: a multicentre, double-blind, randomised, parallel-group, placebo-controlled, phase 2a/b trial - The Lancet Healthy Longevity
![NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62 | Nature Communications NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62 | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-023-44033-0/MediaObjects/41467_2023_44033_Fig1_HTML.png)
NEMO reshapes the α-Synuclein aggregate interface and acts as an autophagy adapter by co-condensation with p62 | Nature Communications
![Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein | Nature Neuroscience Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein | Nature Neuroscience](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41593-022-01239-7/MediaObjects/41593_2022_1239_Fig1_HTML.png)
Post-translational modifications of soluble α-synuclein regulate the amplification of pathological α-synuclein | Nature Neuroscience
![Africa desperately needs to adopt gender-smart and technology-based approaches to capital allocation and financial product design | by The CrossBoundary Group | Medium Africa desperately needs to adopt gender-smart and technology-based approaches to capital allocation and financial product design | by The CrossBoundary Group | Medium](https://miro.medium.com/v2/resize:fit:1200/1*rQr12h1S4Ka6nQ73fkK5zg.png)